欧洲EDITH肾脏病医生调查:影响终末期肾病治疗方式选择的因素
该调查覆盖33个欧洲国家681名肾脏病医生和肾移植外科医生,比较低、中、高GDP购买力平价国家中影响成人ESKD治疗方式选择的因素。结果显示约10%患者开始RRT前未获信息,早期信息提供和患者参与决策在中高GDP国家更常见,对多种治疗态度随GDP增加更积极,障碍发生随GDP增加而减少。结论提示统一泛欧政策可能低效,分国家集群策略或更有效。
要点
- 约10%的ESKD患者在开始RRT前未获得信息。
- 中高GDP国家更常报告早期信息提供和患者参与决策。
- 对多种治疗的态度随GDP增加更积极,障碍随GDP增加减少。
核心结论
- 欧洲低、中、高GDP国家中影响ESKD治疗方式选择的因素存在差异。
- 统一的泛欧政策改善治疗可及性可能低效,分国家集群策略或更有效。
研究设计与样本
- 调查欧洲33个国家681名治疗成人ESKD的肾脏病医生和肾移植外科医生。
- 采用描述性统计比较低、中、高GDP购买力平价国家专业人员的意见。
主要发现
- 所有GDP类别受访者报告约10%患者在开始RRT前未获信息(P=0.106)。
- 中高GDP国家更常报告早期信息提供和更多患者参与决策(P<0.05)。
- 对多种治疗的态度随GDP增加更积极(P<0.05)。
- 73%受访者认为中心血液透析使用充分,但许多人希望增加家庭透析、移植和CCM。
- 财务、人员短缺、空间/物资缺乏和患者相关障碍的发生随GDP增加而减少(P<0.05)。
临床怎么用
- 应关注ESKD患者开始RRT前的信息提供和决策参与。
- 改善治疗可及性需考虑各国GDP差异,避免一刀切政策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Access to forms of dialysis, kidney transplantation (Tx) and comprehensive conservative management (CCM) for patients with end-stage kidney disease (ESKD) varies across European countries. Attitudes of nephrologists, information provision and decision-making may influence this access and nephrologists may experience several barriers when providing treatments for ESKD. METHODS: We surveyed European nephrologists and kidney transplant surgeons treating adults with ESKD about factors influencing modality choice. Descriptive statistics were used to compare the opinions of professionals from European countries with low-, middle- and high-gross domestic product purchasing power parity (GDP PPP). RESULTS: In total, 681 professionals from 33 European countries participated. Respondents from all GDP categories indicated that ∼10% of patients received no information before the start of renal replacement therapy (RRT) (P = 0.106). Early information provision and more involvement of patients in decision-making were more frequently reported in middle- and high-GDP countries (P < 0.05). Professionals' attitudes towards several treatments became more positive with increasing GDP (P < 0.05). Uptake of in-centre haemodialysis was sufficient to 73% of respondents, but many wanted increased uptake of home dialysis, Tx and CCM. Respondents experienced different barriers according to availability of specific treatments in their centre. The occurrence of barriers (financial, staff shortage, lack of space/supplies and patient related) decreased with increasing GDP (P < 0.05). CONCLUSIONS: Differences in factors influencing modality choice when providing RRT or CCM to adults with ESKD were found among low-, middle- and high-GDP countries in Europe. Therefore a unique pan-European policy to improve access to treatments may be inefficient. Different policies for clusters of countries could be more useful.
引用
- de Jong RW, Jager KJ, Vanholder RC, et al. Results of the European EDITH nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease. Nephrol Dial Transplant. 2021. PMID: 33486525. doi:10.1093/ndt/gfaa342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。